药康生物上半年净利润7090.55万元，同比下降7.12%

Group 1 - The core point of the article is that YaoKang Bio reported a revenue of 375 million yuan for the first half of 2025, reflecting a year-on-year growth of 10.11% [1] - The net profit for the same period was 70.91 million yuan, showing a year-on-year decline of 7.12% [1] - The company plans to distribute a cash dividend of 0.3 yuan per 10 shares (including tax), totaling 12.27 million yuan, which represents 17.30% of the net profit attributable to shareholders for the first half of 2025 [1]